Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

10 Tips for Opioid Prescribing

Dennis J. Boyle, MD  |  Issue: December 2014  |  December 1, 2014

The second case revolves around the physician’s legitimate concern about opioid overuse. Did he present a tapering schedule to the patient? Was there an adequate bridge of medicine while the patient transitioned to another provider? Was this physician the first and only prescriber of the opioids? Did the physician discuss the risks, benefits and alternatives of beginning and escalating opioid therapy for a chronic non-cancer indication? These are the questions that will be raised if the physician finds himself defending his actions against an abandonment allegation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Doctors need to understand the true risks to their patients on chronic opioids.
Doctors need to understand the true risks to their patients on chronic opioids.

Discussion

Prior to the 1990s, physicians were prohibited from effectively treating chronic non-cancer pain with high-dose opioids. Pain physicians, advocacy groups and, perhaps, the pharmaceutical industry honed in on our undertreatment of pain, resulting in increased attention to pain—and increased opioid sales.

The common belief was that there was no limit on maximum dosage. Pain was considered the fifth vital sign.1 “Smiley faces” and 10-point pain scales became widespread. Most of us prescribed out of an honest intent to treat pain compassionately and prevent suffering. Perhaps the increased concern for nonsteroidal antiinflammatory drug (NSAID) toxicity, which all rheumatologists were aware of, contributed to the rise of opioid use. In 2011, the Institute of Medicine released the report, “Relieving Pain in America,” in which it was estimated that 100,000 adults are affected by chronic pain.2 Retrospectively, it is clear that there was an absence of evidence-based literature addressing safe and effective opioid use.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Then the tide changed. In 2013, the Centers for Disease Control and Prevention (CDC) published a study indicating a strong association between increased opioid sales and overdose deaths. They estimated that more than 60% of overdose deaths are related to pharmaceuticals. Forty percent of deaths relate to doctor shopping and diversion of these drugs.3 In 2009, more people died accidentally of prescription drug overdoses than from motor vehicle accidents. The 100,000 who are estimated to have died from opioid overdoses from 1999–2010 exceeds the number of American deaths in the Vietnam War.4

Of interest, most of the deaths were unintentional and occurred at home. Opioids have a strong effect on non-REM sleep and are particularly risky when used with sleep aids or benzodiazepines.

Finally, according to the National Institute on Drug Abuse, 2% of Americans are addicted to prescription pain medicine.

Special concern has recently been raised around the issue of morphine-equivalent doses (MEDs) >100 mg. Three different studies suggest a markedly increased risk of death when higher MEDs are used.5,6,7 There is a 3.7–4.3% increased risk when using 50–100 mg daily when compared with 20 mg. Of note, there is an MED calculator from Washington State that is available online8.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:AnalgesicsAxial SpondyloarthritisConditionsDrug UpdatesPain Syndromes Tagged with:Ankylosing SpondylitisBoyleChronic paindruginfliximabopioidPainpatient careprednisoneprescriberheumatologist

Related Articles

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    Are Opioid Contracts Helpful or Harmful?

    October 18, 2019

    The opioid epidemic in the U.S. has destroyed thousands of lives and torn families apart. According to the Centers for Disease Control and Prevention, an average of 130 people in the U.S. die each day from an opioid overdose. From 1999 to 2017, more than 700,000 died as a result of drug overdoses. In 2017,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences